Polyacetylene glycoside attenuates ischemic kidney injury by co-inhibiting inflammation, mitochondria dysfunction and lipotoxicity

Polyacetylene glycoside attenuates ischemic kidney injury by co-inhibiting inflammation, mitochondria dysfunction and lipotoxicity

Accepted Manuscript Polyacetylene glycoside attenuates ischemic kidney injury by coinhibiting inflammation, mitochondria dysfunction and lipotoxicity ...

7MB Sizes 0 Downloads 9 Views

Accepted Manuscript Polyacetylene glycoside attenuates ischemic kidney injury by coinhibiting inflammation, mitochondria dysfunction and lipotoxicity

Yijie Zhou, Dan Du, Shuyun Liu, Meng Zhao, Yujia Yuan, Lan Li, Younan Chen, Yanrong Lu, Jingqiu Cheng, Jingping Liu PII: DOI: Reference:

S0024-3205(18)30249-2 doi:10.1016/j.lfs.2018.05.009 LFS 15703

To appear in:

Life Sciences

Received date: Revised date: Accepted date:

12 March 2018 29 April 2018 3 May 2018

Please cite this article as: Yijie Zhou, Dan Du, Shuyun Liu, Meng Zhao, Yujia Yuan, Lan Li, Younan Chen, Yanrong Lu, Jingqiu Cheng, Jingping Liu , Polyacetylene glycoside attenuates ischemic kidney injury by co-inhibiting inflammation, mitochondria dysfunction and lipotoxicity. The address for the corresponding author was captured as affiliation for all authors. Please check if appropriate. Lfs(2017), doi:10.1016/ j.lfs.2018.05.009

This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.

ACCEPTED MANUSCRIPT

Polyacetylene glycoside attenuates ischemic kidney injury by co-inhibiting inflammation, mitochondria dysfunction and lipotoxicity Yijie Zhou1a, Dan Du2a, Shuyun Liu1, Meng Zhao1, Yujia Yuan1, Lan Li1, Younan Chen1, Yanrong Lu1, Jingqiu Cheng1* and Jingping Liu1* Laboratory of Transplant Engineering and Immunology, Regenerative Medicine Research Center,

PT

1

West China-Washington Mitochondria and Metabolism Center, West China Hospital, Sichuan

SC

2

RI

West China Hospital, Sichuan University, Chengdu, China

University, Chengdu, China Co-first authors

NU

a

MA

*Corresponding author: Jingping Liu

Laboratory of Transplant Engineering and Immunology, Regenerative Medicine Research Center,

D

West China Hospital, Sichuan University, Chengdu 610041, China

PT E

Tel: +86-28-85164029, E-mail: [email protected] *Corresponding author: Jingqiu Cheng

CE

Laboratory of Transplant Engineering and Immunology, Regenerative Medicine Research Center,

AC

West China Hospital, Sichuan University, Chengdu 610041, China Tel: +86-28-85164029, E-mail: [email protected]

1

ACCEPTED MANUSCRIPT

Abstract Aims: Ischemic acute kidney injury (AKI) is a serious clinical problem and no efficient therapeutics is available in clinic now. Natural polyacetylene glycosides (PGAs) had shown antioxidant and anti-inflammatory properties, but their effects on kidney injury have not been

PT

evaluated. This study aimed to investigate the protective effect of PGA on ischemic kidney injury

RI

in renal tubular epithelial cells (TECs) and mice.

SC

Main methods: Hypoxic HK-2 cells and renal ischemia/reperfusion injury (IRI) mice were treated with PGA from Coreopsis tinctoria, and the cell viability, renal function, apoptosis,

NU

inflammation, mitochondrial injury, lipids metabolism were analyzed.

MA

Key findings: In vitro results showed that PGA improved cell viability and reduced oxidative stress, pro-apoptotic / pro-inflammatory factors expression and NFκB activation in TECs under

D

hypoxia/reperfusion (H/R). Moreover, PGA reduced mitochondria oxidative stress and improved

PT E

ATP production, ΔΨm and mitochondria biogenesis, and inhibited lipids uptake, biosynthesis and accumulation in hypoxic TECs. In vivo, PGA significantly attenuated kidney injury and reduced

CE

blood urea nitrogen (BUN), serum creatinine (CREA) and urinary albumin (Alb), and increased

AC

creatinine clearance (CC) in IRI mice. PGA also decreased cell apoptosis, mitochondria oxidative stress, inflammatory response and lipid droplets accumulation, and promoted ATP generation in kidney of IRI mice.

Significance: Our results proved that PGA ameliorated ischemic kidney injury via synergic anti-inflammation, mitochondria protection and anti-lipotoxicity actions, and it might be a promising multi-target therapy for ischemic AKI. Keywords: acute kidney injury; inflammation; polyacetylenes glycoside; lipotoxicity; 2

ACCEPTED MANUSCRIPT mitochondria Abbreviations AKI, acute kidney injury; ATP5a1, ATP synthase, H+ transporting, mitochondrial F1 complex, alpha 1; Bax, BCL2 associated X; BUN, blood urea nitrogen, CREA, serum creatinine; CC,

PT

creatinine clearance; CCK-8, cell counting kit-8; CD36, cluster of differentiation 36; CPT-1,

RI

Carnitine palmitoyl-transferase 1; DAPI, 4',6-diamidino-2-phenylindole; FASN, fatty acid

SC

synthase; GAPDH, glyceraldehyde 3 phosphate dehydrogenase; HK2, Human renal proximal tubule epithelial cell line; H/R, hypoxia/reperfusion; ICAM-1, intercellular adhesion molecule-1;

NU

IL-1β, interleukin-1β; MCP-1, monocyte chemoattractant protein-1; NF-κB, nuclear factor-κB;

MA

PPAR-α, peroxisome proliferator activated receptor alpha; PGA, polyacetylenes glycosides; PGC-1α, Peroxisome proliferator-activated receptor-γ co-activator 1-α; ROS, reactive oxygen

D

species; SCD1, stearoyl-CoA desaturase-1; TECs, renal tubular epithelial cells; TNF-α, tumor

AC

CE

PT E

necrosis factor α.

3

ACCEPTED MANUSCRIPT

1. Introduction Acute kidney injury (AKI) is a serious worldwide clinical problem characterized by a rapid decrease in kidney function with high mortality and morbidity, and ischemia is one of the main causes for AKI [1-3]. Moreover, incomplete recovery of AKI further induces the development of

PT

chronic kidney disease (CKD) [3]. The pathophysiology of AKI is complex and many factors such

RI

as oxidative stress, inflammation and apoptosis are involved [1]. Currently, numerous single-target

SC

therapies for AKI such as antioxidants and anti-inflammatory agents have been developed, but their renal outcomes need to be improved to meet clinical demands. Thus, novel effective agents

NU

for AKI are still desired.

MA

It was well-documented that mitochondrial dysfunction played an essential role in the initiation and progression of AKI [4]. Previous study reported a persistent disruption of mitochondrial

D

homeostasis in renal tubules after ischemia-reperfusion (I/R) injury [5]. Hypoxia induced cytosolic

PT E

calcium overload, mitochondrial stress and energy depletion in the renal tubular cells [4-6] . Mitochondrial injury during AKI further impaired energy-dependent renal repair mechanism, and

CE

led to oxidative stress and cell death in hypoxic renal tubular cells and kidney [5-7]. In addition,

AC

renal lipid metabolism disorder was also involved in renal fibrosis after AKI. Previous studies found obvious lipids including fatty acids (FA) deposition in the renal tubular cells of AKI mice and patients [8-10], and suggested that lipotoxicity played an important role in the development of renal fibrosis after AKI [8]. The accumulated FAs in kidney during H/R further induced sustained mitochondrial depolarization and energetic deficit in renal tubules after AKI [10]. Therefore, these studies suggested that renal mitochondria injury and lipid metabolism disorder might serve as potential therapeutic targets for AKI. 4

ACCEPTED MANUSCRIPT Polyacetylene belongs to a class of compounds characterized by the presence of two or more carbon-carbon triple bonds in the carbonic skeleton [11]. Natural polyacetylene and its derivatives such as polyacetylene glucoside (PGA) were widely distributed in various food and medical plants, and they exerted multiple bioactivities such as anti-inflammatory, anti-microbial and anti-allergic

PT

effects [12,13]. It had been reported that PGA from purple carrots reduced LPS-induced nitric

RI

oxide (NO), iNOS and pro-inflammatory cytokines such as IL-6, IL-1β and TNF-α production in

SC

macrophage and endothelial cells [14]. We had previously isolated a new linear C14 PGA from Coreopsis tinctoria that was traditionally used as tea-like beverage to prevent cardiovascular

NU

diseases in Chinese folk medicine, and proved that it reduced lipids accumulation in 3T3-L1

MA

adipocytes [15]. In addition, PGA from Coreopsis tinctoria showed anti-inflammatory activity via inhibiting COX-2 in macrophages [12]. Although the anti-inflammatory and anti-lipogenic role of

D

PGA were reported, its effect on AKI has not been fully illustrated.

PT E

In this study, we purposed to evaluate the renal protective role of natural PGA isolated from Coreopsis tinctoria on H/R-induced TECs injury and IRI-induced AKI mice, and its potential

CE

effective mechanism were further revealed.

AC

2. Materials and Methods

2.1. Cell culture and treatment Human renal proximal tubule epithelial cell line (HK2) were cultured in Dulbecco’s modified Eagle’s medium (DMEM, Invitrogen) supplemented with 10% fetal bovine serum (Gibco, CA, USA), 50 U/ml penicillin and 50 µg/ml streptomycin in a humidified atmosphere at 37°C with 5% CO2. To induce H/R injury, HK2 cells were incubated in a hypoxic chamber (≤1% O2, 5% CO2, 94% N2) at 37°C for 24 h and followed with reoxygenation (21%O2, 5% CO2, 74% N2) for 2 h. The 5

ACCEPTED MANUSCRIPT linear C14 PGA was isolated from Coreopsis tinctoria as previously described [15], and its chemical structure was shown in Fig. S1. HK-2 cells were treated with 80 μM PGA in the H/R experiments (n=3 per group). 2.2. Cell viability assay

PT

Cells were seeded in 96-well plate and incubated in H/R condition and treated with PGA. After

RI

treatment, CCK8 solution (Dojindo, Kumamoto, Japan) was added and incubated with cells at

SC

37°C for 2 h. The absorbance at 450 nm was measured by microplate reader (BioTek Instruments

group to the control group.

MA

2.3. Cell Annexin V-FITC / PI staining

NU

Inc, USA). The cell viability was calculated by normalizing optical density of the experimental

Cell apoptosis was detected by using Annexin V-FITC and propidiumiodide (PI) staining kit

D

(BD Biosciences, USA). Briefly, cells were washed with PBS and stained with 5 μl of Annexin

PT E

V-FITC and 10 μl of PI solution in binding buffer for 15 min at room temperature in the dark. The stained cells were then observed by fluorescence microscope (Axio Observer D1, Carl Zeiss,

CE

Germany). The apoptotic rates were expressed as the percentage of apoptotic cells normalized to

AC

total cells in the sections. The experiment was repeated three times independently, and ten randomly selected fields per slides were recorded each time. 2.4. Measurement of intracellular ROS 2’7’-Dichlorofluorescein diacetate (DCFH-DA, Sigma, USA), Dihydroethidium (DHE, Thermo Fisher Scientific, USA) and MitoSOX (Molecular Probes, Thermo Fisher Scientific) were used to measure intracellular ROS. After treatment, cells were incubated with 10 μM DCFH-DA / DHE at 37°C for 30 min, or 5 μM MitoSOX at 37°C for 10 min. After washing with PBS, digital images 6

ACCEPTED MANUSCRIPT were captured by fluorescent microscope (Axio Observer D1, Carl Zeiss, Germany). For images analysis, three slides of different samples in each group were chose, and ten randomly selected fields per slides were recorded, and the mean fluorescence intensity in each image was analyzed by NIH Image J software.

PT

2.5. Quantitative real-time PCR (qPCR)

RI

Total RNA was extracted by Trizol (Gibco, Life Technologies, CA, USA) and

SC

reverse-transcribed into cDNA by iScript cDNA synthesis kit (Bio-Rad, USA). Real-time polymerase chain reaction (Real time-PCR) was performed on CFX96 real-time PCR detection

NU

system (Bio-Rad, USA) with SYBR Green (Bio-Rad, USA). The mice primers including cluster of

MA

differentiation 36 (CD36), fatty acid synthase (FASN) and stearoyl-CoA desaturase-1 (SCD1) were purchased from GeneCopoeia Company (Rockville, MD, USA), and the sequences of other

D

primers were listed in Table S1. qPCR data were analyzed by Bio-Rad CFX Manager software,

reference gene.

CE

2.6. Western blot

PT E

and the relative change of mRNA was calculated by delta-delta Ct method with GAPDH as

AC

Cells and kidney tissues were lysed in radioimmuno-precipitation assay (RIPA) buffer supplemented with protease and phosphatase inhibitors (Calbiochem, CA, USA). Protein concentration was determined by BCA Assay Kit (CWBIO, China). Equal amount of protein was subjected to electrophoresis on 12% SDS-PAGE, and then transferred to PVDF membranes (Merck Millipore, USA). PVDF membranes were blocked with 5% non-fat milk and incubated with primary antibodies against Bax (1:1000, 2772S, CST, USA), Bcl-2 (1:500, A2212, ABclonal, USA), ICAM-1 (1:1000, 10831-1-AP, Proteintech, USA), IL-1β (1:1000, A1112, ABclonal, USA), 7

ACCEPTED MANUSCRIPT p-NFκB (1:1000, 3033S, CST, USA), NFκB (1:500, 4764S, CST, USA), PGC-1α (1:1000, 20658-1-AP, Proteintech, USA), ATP5a1 (1:1000, A5884, ABclonal, USA), CPT1A (1:1000, 15184-1-AP, Proteintech, USA) and PPARα (1:1000, 15540-1-AP, Proteintech, USA) overnight at 4 °C. After washing with PBST, PVDF membranes were incubated with HRP-conjugated

PT

secondary antibody (1:2000, AS014, ABclonal, USA) at 37 °C for 1 h. Protein bands were

RI

detected by chemiluminescence kit (Millipore, USA) and quantified by NIH Image J software.

SC

2.7. Immunofluorescence (IF) staining

Cells and frozen kidney tissue sections were fixed with 4% paraformaldehyde in PBS for 10

NU

min at room temperature, and then washed with PBS and permeabilized with 0.3% Triton X-100

MA

for 10 min. After blocking in 1% BSA for 60 min, cells were incubated with rabbit anti-NFκB antibody (1:200, 4764S, CST, USA), rabbit anti-ICAM-1 antibody (1:200, 10831-1-AP,

D

Proteintech, USA), rabbit anti-IL-1β antibody (1:200, A1112, ABclonal, USA), rabbit anti-Bax

PT E

antibody (1:200, 2772S, CST, USA), rabbit anti-PGC1α antibody (1:200, 20658-1-AP, Proteintech, USA), rabbit anti-ATP5a1 antibody (1:200, A5884, ABclonal, USA), rabbit anti-CPT1A antibody

CE

(1:200, 15184-1-AP, Proteintech, USA) and rabbit anti-PPARα antibody (1:200, 15540-1-AP,

AC

Proteintech, USA) overnight at 4 °C. After washing with PBS, cells were incubated with FITC or TRITC conjugated secondary antibody (1:500, Abcam, UK) for 1 h at 37 °C. Nuclei were visualized by staining with DAPI (1:1000, Sigma, USA). Ten visual fields in three sections of each group were randomly selected and digital images were captured by fluorescent microscope (Imager Z2, Zeiss, Germany). The mean fluorescence intensity of images was semi-quantitative analyzed by NIH Image J software. 2.8. Measurement of cellular and tissue ATP 8

ACCEPTED MANUSCRIPT The ATP level was determined by ATP Bioluminescence Assay Kit (Beyotime, China) according to the manufacturer’s protocol. Briefly, cells and fresh kidney tissues were harvested and lysed in a lysis buffer, followed by centrifugation at 12,000 g for 5 min at 4°C. The level of ATP was determined by mixing 100 μl of the supernatant with 100 μl of luciferase reagent, which

PT

catalyzed the luminescence production from ATP and luciferin. The emitted luminescence was

RI

measured by microplate luminometer (Synergy4 Mx, Bio-Tek, USA).

SC

2.9. Mitochondrial membrane potential assay

Mitochondrial membrane potential (ΔΨm) was measured by tetramethylrhodamine methyl ester

NU

(TMRM, Invitrogen, USA). After treatment, the cells were incubated with 100 nM TMRM for 20

MA

min at 37 °C. After washing with PBS, the digital images of stained cells were captured by fluorescent microscope (Eclipse TS100, Nikon, Japan). Ten randomly selected fields in three

D

stained cells were record, and the mean fluorescent intensity was analyzed by NIH Image J

PT E

software.

2.10. Cellular Oil-Red O (ORO) staining

CE

To mimic renal lipid metabolism in vitro, HK-2 cells were cultured in media supplemented with

AC

palmitic acid (50 μM, Aladdin, China) dissolved in BSA solution. After treatment, cells were washed with PBS and fixed with 10% (v/v) formalin for 10 min at room temperature. After fixation, the cells were washed with PBS and 60% (v/v) isopropanol, and then stained with a filtered Oil-Red solution (Nanjing Jiancheng Bioengineering Institute, China) for 30 min and observed by light microscope (Eclipse TS100, Nikon, Japan). To quantify the intracellular lipids, stained lipid droplets in cells were dissolved in isopropanol for 10 min, and the absorbance at 545 nm was measured. 9

ACCEPTED MANUSCRIPT

2.11. Mouse renal IRI model and treatment All animal experiments were approved and conducted according to the guidelines of Animal Care and Use Committee of Sichuan University. Adult male C57BI/6J mice (20-25 g) were purchased from Experimental Animal Center of Sichuan University (Chengdu, China). Animals

PT

were housed in individual cage with controlled temperature, humidity and 12 h cycles of light and

RI

darkness, and fed with standard chow and tap water ad libitum. Animals were random divided into

SC

four groups: Control (sham, n=6), IRI (n=6), IRI + DMSO (vehicle, n=6) and IRI + PGA (n=6). Animals were anesthetized by 1% pentobarbital sodium, and placed in a supine position on a

NU

warming pad at 37°C for midline laparotomy. The kidney IRI injury was induced by clamping the

MA

renal pedicles for 30 min using non-traumatic vascular clips, while sham group received laparotomy without ischemia. After surgery, IRI mice were i.p. injected with 100 μl DMSO (2.5 %,

D

dissolved in PBS) or PGA (50 mg/kg, dissolved in DMSO/PBS), respectively. Mice in each group

PT E

were sacrificed by overdose of anesthesia at day 3 after surgery, and kidney tissue and serum were collected for further tests.

CE

2.12. Biochemical measurement

AC

Clinical biochemistry analysis of creatinine (CREA), urea nitrogen (BUN) and urinary albumin (Alb) from mice was performed on an Automatic Biochemistry Analyzer (Cobas Integra 400 plus, Roche) by using appropriate kits. Creatinine clearance (CC) was calculated as (urine volume × urine CREA) / serum CREA according to the previous reported [16]. 2.13. Histological examination The kidney removed from mice were fixed in 4% paraformaldehyde, embedded in paraffin and sliced into 5 μm sections. Paraffin renal sections were stained with H&E by standard protocols. 10

ACCEPTED MANUSCRIPT Digital images of HE sections were acquired by light microscope, and the areas of necrotic tubules were quantified by Image J software as described above. 2.14. Kidney cell apoptosis TUNEL assay The apoptotic cells in frozen kidney sections were detected by TUNEL staining kit (Promega,

PT

USA) according to the manufacturer’s instruction, and the nucleus was labeled by Hoechest 33258

RI

(Sigma, USA). The stained kidney sections were observed by fluorescence microscope (Imager Z2,

SC

Zeiss, Germany). The rate of apoptotic cells in each group was calculated by average of TUNEL-positive apoptotic cells in ten fields from each kidney sample.

NU

2.15. Kidney lipids Nile red staining

MA

The frozen renal sections were fixed in 4% paraformaldehyde and stained with Nile red (MCE, USA) at a final working concentration of 10 μg/ml in acetone/water (1:9) mixture. Nile red stained

D

renal tissue sections were visualized by fluorescent microscope (Imager Z2, Zeiss, Germany) at

Image J software.

PT E

Ex485/Em525 nm. The mean fluorescence intensity of images from each sample was analyzed by

CE

2.16. Statistical analysis

AC

All data expressed as mean ± SD were analyzed by one or two-way ANOVA test with Tukey’s post hoc analysis using SPSS software (version 11.5, IBM Corporation, USA), and p<0.05 was considered as significant difference. 3. Results 3.1. PGA alleviated H/R-induced cell apoptosis and oxidative stress in TECs CCK8 results showed that PGA enhanced HK-2 cell viability in a dose-dependent manner (20-150 μM) under H/R, and DMSO (vehicle) did not affect the viability of hypoxic TECs (Fig. 11

ACCEPTED MANUSCRIPT 1A). PGA exerted best protective role on TECs viability at 80-150 μM under H/R stress, but there was no significant difference between 80,100 and 150 μM groups. Thus, the lower and effective concentration (80 μM) was used in following cell experiments. H/R induced apoptosis in HK-2 cells, whereas PGA reduced apoptotic rates of TECs during H/R (Fig. 1B-C). PGA also reduced

PT

pro-apoptotic Bax and Fas expression, and enhanced anti-apoptotic Bcl-2 expression (Fig. 1D-E).

CE

PT E

D

MA

NU

SC

RI

In addition, PGA inhibited intracellular ROS generation in HK-2 cells under H/R (Fig. 1F).

AC

Fig. 1 Effects of PGA on cell viability, apoptosis and oxidative stress in HK-2 cells during H/R. (A) Cell viability was determined by CCK8 assay. (B) Cell apoptosis was detected by Annexin V-FITC/PI staining (Scale bar = 25 μm). (C) Quantification analysis of cell apoptotic rates determined by Annexin V-FITC/PI staining. (D) Real-time PCR analysis of Fas and Bax mRNA. (E) Western blot and quantification analysis of BAX and Bcl-2 protein level. (F) Intracellular ROS measured by DHE and DCF staining (Scale bar = 25μm), *p<0.05, H/R group vs control, #p<0.05, PGA group vs H/R group, (n=3 per group). 12

ACCEPTED MANUSCRIPT

3.2. PGA reduced inflammatory factors expression in TECs under H/R The qPCR data showed that PGA inhibited ICAM-1, TNF-α, IL-6 and HMGB1 expression in TECs under H/R (Fig. 2A). Western blot (Fig. 2B) and IF staining (Fig. 2D) results proved that PGA reduced ICAM-1 and IL-1β protein in TECs under H/R, while DMSO could not inhibit

PT

IL-1β in H/R-treated TECs (Fig. S2). PGA also reduced p-NFκB protein in H/R-treated TECs (Fig.

CE

PT E

D

MA

NU

SC

RI

2C), and inhibited the nuclear translocation of NFκB p65 induced by H/R (Fig. 2D).

AC

Fig. 2 Effects of PGA on inflammatory response in HK-2 cells during H/R. (A) Real-time PCR analysis of HMGB1, ICAM-1, TNF-α and IL-6 mRNA levels. (B) Western blot and quantification analysis of ICAM-1 and IL-1β protein levels. (C) Western blot and quantification analysis of p-NFκB level. (D) IF staining of ICAM-1, IL-1β and NFκB p65 in HK-2 cells (Scale bar = 25 μm), *p<0.05, H/R group vs control, #p<0.05, PGA group vs H/R group, (n=3 per group). 3.3. PGA restored mitochondria function in TECs under H/R stress H/R induced severe mitochondria injury in TECs, while PGA significantly enhanced cellular 13

ACCEPTED MANUSCRIPT ATP (Fig. 3A) and mitochondrial membrane potential (Fig. 3B), and reduced mtROS in TECs under H/R (Fig. 3B). In addition, PGA reversed the decline of PGC-1α, ATP5a1, COX5b and SDHb in hypoxic TECs (Fig. 3C). Western blot results confirmed that PGA increased PGC-1α and ATP5a1 protein level in H/R-treated TECs (Fig. 3D), and DMSO had no effect on ATP5a1

CE

PT E

D

MA

NU

SC

RI

PT

expression (Fig. S2).

AC

Fig. 3 Effects of PGA on mitochondrial injury in HK-2 cells during H/R. (A) Measurement of intracellular ATP level. (B) mtROS and mitochondrial membrane potential were determined by MitoSOX Red and TMRM staining, respectively (Scale bar = 25 μm). (C) Real-time PCR analysis of PGC-1α, ATP5a1, COX5b and SDHb mRNA. (D) Western blot and quantification analysis of PGC-1α and ATP5a1 protein, *p<0.05, H/R group vs control, #p<0.05, PGA group vs H/R group, (n=3 per group). 3.4. PGA reduced intracellular lipid accumulation in TECs under H/R 14

ACCEPTED MANUSCRIPT H/R promoted lipid droplets formation in TECs, while PGA decreased the lipid accumulation in hypoxic TECs (Fig. 4A-B). H/R increased CD36, SCD1 and FASN, and inhibited CPT1 in TECs, while PGA reduced CD36, SCD1 and FASN but enhanced CPT1 in hypoxic TECs (Fig. 4C). Western blot and IF staining results showed that PGA up-regulated PPARα and CPT1A protein in

CE

PT E

D

MA

NU

SC

RI

PT

hypoxic TECs (Fig. 4D-E), and DMSO failed to rescue CPT1A in TECs under H/R (Fig. S2).

Fig. 4 PGA decreased lipid metabolism disorder in HK-2 cells during H/R. (A) Measurement of

AC

intracellular lipids by ORO staining (Scale bar= 25 μm). (B) Quantification analysis of lipids detected by ORO staining. (C) Real-time PCR analysis of CD36, FASN, SCD1 and CPT1 mRNA. (D) Western blot and quantification analysis of CPT1A and PPARα protein level. (E) IF staining of CPT1A and PPARα in HK-2 cells (Scale bar = 25μm), *p<0.05, H/R group vs control, #p<0.05, PGA group vs H/R group, (n=3 per group). 3.5. PGA attenuated renal injury and tubular apoptosis in IRI mice

15

ACCEPTED MANUSCRIPT IRI mice showed severe kidney injury as indicated by increased level of serum BUN / CREA, urinary albumin (Fig. 5A) and tubular necrosis (Fig. 5C-D), and decreased creatinine clearance (Fig. 5A) compared to controls. By contrast, PGA reduced serum BUN / CREA, urinary albumin and necrotic tubules, and reversed decline of creatinine clearance in IRI mice. Moreover, PGA

PT

decreased the level of tubular cells apoptosis and pro-apoptotic Bax and Fas, and enhanced

RI

anti-apoptotic Bcl-2 expression in IRI mice (Fig. 5B-E). DMSO showed no protective effect on

AC

CE

PT E

D

MA

NU

SC

renal injuries in IRI mice (Fig. 5A-E).

Fig. 5 PGA improved kidney function in IRI mice. (A) Serum CREA, BUN, urinary albumin and creatinine clearance at 3 days after surgery. (B) Real-time PCR analysis of Fas and Bax mRNA. (C) H&E and TUNEL staining of kidney tissues from mice (Scale bar = 25 μm). (D) The percentage of necrotic tubules and TUNEL+ apoptotic cells at in mice 3 days after IRI. (E) Western blot and quantification analysis of BAX and Bcl-2 protein level. *p<0.05, IRI group vs 16

ACCEPTED MANUSCRIPT control, #p<0.05, PGA group vs IRI group, (n=6 per group). 3.6. PGA ameliorated renal inflammatory responses in IRI mice IRI mice showed increased pro-inflammatory factors including HMGB1, ICAM-1and IL-1β mRNA, and ICAM-1 and IL-1β protein expression compared to controls (Fig. 6A-D). In contrast,

PT

PGA inhibited HMGB1, ICAM-1and IL-1β mRNA, and ICAM-1 and IL-1β protein levels

AC

CE

PT E

D

MA

NU

SC

factors expression in the kidney of IRI mice (Fig. 6A-D).

RI

compared to IRI groups (Fig. 6A-D). DMSO alone could not inhibit these pro-inflammatory

Fig.6 PGA reduced inflammatory response in kidneys after IRI. (A) Real-time PCR analysis of HMGB1, ICAM-1 and IL-1β mRNA levels. (B) Western blot analysis of ICAM-1 and IL-1β protein. (C) Quantification analysis of ICAM-1 and IL-1β protein levels. (D) IF staining of IL-1β in kidneys (Scale bar = 25 μm), *p<0.05, IRI group vs control, #p<0.05, PGA group vs IRI group, (n=6 per group). 3.7. PGA rescued renal mitochondrial dysfunction in IRI mice 17

ACCEPTED MANUSCRIPT IRI mice showed increased renal mitochondria oxidative stress and impaired function compared to controls (Fig. 7), while PGA significantly reduced mtROS (Fig. 7A), restored ATP production (Fig. 7B), and enhanced renal mitochondria biogenesis proteins PGC-1α and ATP5a1 expression in IRI mice (Fig. 7C-F). Meanwhile, DMSO did not significantly improve renal mitochondria

CE

PT E

D

MA

NU

SC

RI

PT

function in IRI mice (Fig. 7).

AC

Fig.7 PGA rescued kidney mitochondrial function after IRI. (A) mtROS was determined by MitoSOX Red staining (Scale bar = 25 μm). (B) Measurement of kidney ATP level. (C) Real-time PCR analysis of PGC-1α and ATP5a1 mRNA. (D-E) Western blot and quantification analysis of PGC-1α and ATP5a1 protein levels. (F) IF staining of ATP5a1 in kidney from mice (Scale bar = 25 μm). *p<0.05, IRI group vs control, #p<0.05, PGA group vs IRI group, (n=6 per group). 3.8. PGA prevented renal lipids deposition in IRI mice Nile red staining results showed increased lipid contents accumulation in the kidney tubules of 18

ACCEPTED MANUSCRIPT IRI and IRI + DMSO groups compared to control group, whereas PGA significantly reduced the renal lipid deposition in IRI mice (Fig. 8A). In addition, our data showed decline of PPARα and CTP1A mRNA and protein in the kidney of IRI mice, while PGA group had higher level of

PT E

D

MA

NU

SC

RI

PT

PPARα and CTP1A than those of IRI and IRI + DMSO groups (Fig. 8B-E).

CE

Fig.8 PGA decreased renal lipid accumulation in mice after IRI. (A) Nile red staining and

AC

quantification analysis of lipids in kidney. (B) Real-time PCR analysis of PPARα and CPT1 mRNA. (C) Western blot analysis of PPARα and CPT1A proteins. (D) Quantification analysis of PPARα and CPT1A proteins. (E) IF staining of PPARα in kidneys (Scale bar = 25μm). *p<0.05, IRI group vs control, #p<0.05, PGA group vs IRI group, (n=6 per group). 4. Discussion IRI led to severe kidney injury associated with of morbidity and mortality, and increased the risk of CKD in patients [17]. Currently, there are no effective therapeutic agents available for AKI 19

ACCEPTED MANUSCRIPT in clinic [2]. Therefore, novel effective agents for AKI are urgently needed. In this study, we aim to evaluate the protective role of natural PGA on I/R-induced injury in vitro and vivo. Oxidative stress, inflammation and cell apoptosis were well-known features in kidney after AKI [1]. Renal tubules were the initial regions affected by I/R injury, which triggered the release of

PT

inflammatory factors and subsequently recruited pro-inflammatory cells such as neutrophils and

RI

macrophages infiltration into the tubulointerstitium, and in turn led to cell death and further

SC

development of renal fibrosis after AKI [1]. NFκB pathway played a key role in inflammation by regulating pro-inflammatory cytokines, chemokines and cell adhesion molecules expression [18].

NU

Meanwhile, oxidative stress had a vital relationship with the inflammation via activation of NFκB

MA

pathway [19]. In this study, our data proved that PGA had protective role on AKI, which could reduce cellular ROS and apoptosis in TECs under H/R and improved renal function in IRI mice.

D

Moreover, PGA suppressed NFκB activation and inflammatory factors expression in hypoxic

PT E

TECs and ameliorated renal macrophages infiltration and pro-inflammatory cytokines release in the IRI mice. The anti-inflammatory effect of PGA had been previously reported, which inhibited

CE

the release of inflammatory factors and NFκB signaling in macrophages and endothelial cells

AC

[14,20]. Therefore, our results indicated that PGA ameliorated ischemic kidney injury partly due to its direct anti-inflammation action. Mitochondria played essential roles in mediating cellular energy metabolism, survival and apoptotic pathways response to stress stimuli [21,22]. Previous studies found that I/R caused persistent mitochondria injury and energy deletion in tubular cells after AKI [5]. It had been proposed that mitochondria protection was a promising strategy for ischemic kidney and cardiovascular diseases [22], and mitochondria-targeted antioxidants such as SS31 promoted 20

ACCEPTED MANUSCRIPT mitochondria recovery after ischemia and thus reduced AKI in rodent model [23]. Our results showed severe mitochondria dysfunction as indicated by elevated mtROS, and reduced ATP generation, ΔΨm and mitochondria biogenesis genes in TECs under H/R and kidney of IRI mice. By contrast, PGA effectively alleviated mitochondrial injuries and restored energy metabolism in

PT

vitro and in vivo. Peroxisome proliferator-activated receptor-γ co-activator 1-α (PGC1α) was a

RI

master regulator of mitochondrial biogenesis, and activation of PGC1α had shown to promote

SC

kidney recovery after IRI in mice [24]. Our data showed that PGA promoted PGC1α expression in hypoxic TECs and kidney of IRI mice. Thus, our results suggested that PGA preserved ischemic

NU

renal injury via enhancing mitochondria function and PGC-1α pathway.

MA

Previous studies had found increased lipids including FAs accumulation in hypoxic renal tubules, and suggested that overloaded FAs induced-lipotoxicity contributed to the development of

D

kidney fibrosis after AKI [8,10,25]. In this study, we observed elevated lipids deposition

PT E

associated with up-regulation of lipogenic genes such as SCD1, CD36 and FASN in hypoxic TECs and kidney of IRI mice, while PGA reduced tubular lipids accumulation and lipogenic

CE

genes expression. These results suggested that PGA could block the abnormal FA uptake and

AC

biosynthesis in TECs under I/R. FAs were important mitochondrial substrates in proximal tubules, and could be oxidized (β-oxidation) to meet renal metabolic demand [8,10]. Carnitine palmitoyl-transferase 1 (CPT1) was a rate-limiting enzyme of β-oxidation in the step of FAs entry into mitochondria[26]. Dysfunction of CPT-1 and FAs β-oxidation contributed to hypoxia-induced lipids accumulation in hepatocytes [26]. PPARα was a member of steroid /nuclear receptor super family, which played a key role in maintaining FAs and ATP metabolism homeostasis in kidney PTECs [27]. In this study, we found that PGA enhanced both CPT1 and PPARα expression in 21

ACCEPTED MANUSCRIPT hypoxic TECs and kidney of IRI mice, which indicated that PGA reduced I/R induced tubular lipid accumulation by promoting FAs β-oxidation. Therefore, our results suggested that PGA exerted its renoprotection via restoring lipid metabolism and inhibiting lipotoxicity in TECs after AKI.

PT

In summary, our study showed that I/R caused severe cell apoptosis, inflammation, oxidation

RI

stress, mitochondria dysfunction and lipid accumulation in hypoxic TECs and kidney of IRI mice,

SC

whereas PGA significantly ameliorated these adverse effects in vitro and in vivo. We further revealed that PGA inhibited inflammatory factors release by inactivating NFκB pathway, restored

NU

mitochondria function via promoting PGC1α signaling, and reversed lipid metabolism disorder by

MA

enhancing CPT1/PPARα pathways in hypoxic TECs and kidney of IRI mice. This study suggested that PGA attenuated ischemic AKI via synergic anti-inflammation, mitochondrial protection and

PT E

Conflicts of interest

D

anti-lipotoxicity mechanism.

The authors have declared no conflicts of interest.

CE

Acknowledgments

AC

This work was supported by grants from National Natural Science Foundation of China (31200754, 81571808) and China Postdoctoral Science Foundation (2012M511931). References

[1] Agarwal A, Dong Z, Harris R, Murray P, et al., Cellular and Molecular Mechanisms of AKI, J Am Soc Nephrol. 27(9) (2016) 1288-99. [2] Kaushal GP, Shah SV, Challenges and advances in the treatment of AKI, J Am Soc Nephrol. 25(5) (2014) 877-83. [3] Venkatachalam MA, Griffin KA, Lan R, Geng H, et al., Acute kidney injury: a springboard for progression in chronic kidney disease, Am J Physiol Renal Physiol. 298(5) (2010) 22

ACCEPTED MANUSCRIPT F1078-F1094. [4] Weinberg JM, Mitochondrial Biogenesis in Kidney Disease, J Am Soc Nephrol. 22(3) (2011) 431-436. [5] Funk JA, Schnellmann RG, Persistent disruption of mitochondrial homeostasis after acute kidney injury, Am J Physiol Renal Physiol. 302(7) (2012) F853-F864.

PT

[6] Funk JA, Odejinmi S, Schnellmann RG, SRT1720 induces mitochondrial biogenesis and rescues mitochondrial function after oxidant injury in renal proximal tubule cells, J

RI

PharmacolL Exp The. 333(2) (2010) 593-601.

[7] Sharfuddin AA, Molitoris BA, Pathophysiology of ischemic acute kidney injury, Nat Rev

SC

Nephrol. 7(4) (2011) 189-200.

[8] Simon N, Hertig A, Alteration of Fatty Acid Oxidation in Tubular Epithelial Cells: From

NU

Acute Kidney Injury to Renal Fibrogenesis, Front Med (Lausanne). 2 (2015) 52. [9] Portilla D, Role of fatty acid beta-oxidation and calcium-independent phospholipase A2 in

MA

ischemic acute renal failure, Curr Opin Nephrol Hyperten. 8(4) (1999) 473-477. [10] Feldkamp T, Kribben A, Roeser NF, Senter RA, Accumulation of nonesterified fatty acids the

sustained

deficit

in

kidney

proximal

tubules

after

Am J Physiol Renal Physiol. 290(2) (2006) F465-F477.

PT E

hypoxia-reoxygenation,

energetic

D

causes

[11] Negri R, Polyacetylenes from terrestrial plants and fungi: Recent phytochemical and biological advances, Fitoterapia. 106 (2015) 92-109.

CE

[12] Zhang Y, Shi S, Zhao M, Chai X, Coreosides A-D, C14-polyacetylene glycosides from the capitula of Coreopsis tinctoria and its anti-inflammatory activity against COX-2, Fitoterapia.

AC

87(2013) 93-97.

[13] LP C, Bioactivity of polyacetylens in food plants: Bioactive Foods in Promoting Health (Chapter 20), San Diego, Academic Press, 2010. [14] Metzger BT, Barnes DM, Reed JD, Purple carrot (Daucus carota L.) polyacetylenes decrease lipopolysaccharide-induced expression of inflammatory proteins in macrophage and endothelial cells, J Agric Food Chem. 56(10) (2008) 3554-3560. [15] Du D, Jin T, Xing ZH, Hu LQ, One new linear C14 polyacetylene glucoside with antiadipogenic activities on 3T3-L1 cells from the capitula of Coreopsis tinctoria, J Asian Nat Prod Res. 18(8) (2016) 784-790. 23

ACCEPTED MANUSCRIPT [16] Toblli JE, Cao G, Rico L, Angerosa M, Cardiovascular, liver, and renal toxicity associated with an intravenous ferric carboxymaltose similar versus the originator compound, Drug design, development and therapy. 11 (2017) 3401–12. [17] Rabb H, Griffin MD, McKay DB, Swaminathan S, et al., Inflammation in AKI: Current Understanding, Key Questions, and Knowledge Gaps, J Am Soc Nephrol. 27(2) (2016)

PT

371-379. [18] Liu S, Yuan Y, Zhou Y, Zhao M, et al., Phloretin attenuates hyperuricemia-induced

RI

endothelial dysfunction through co-inhibiting inflammation and GLUT9-mediated uric acid uptake, J Cell Mol Med. 21(10) (2017) 2553-2562.

SC

[19] Morgan MJ, Liu ZG, Crosstalk of reactive oxygen species and NF-kappaB signaling, Cell Res. 21(1) (2011)103-115.

NU

[20] He J, Shen Y, Jiang JS, Yang YN, et al., New polyacetylene glucosides from the florets of Carthamus tinctorius and their weak anti-inflammatory activities, Carbohydr Res. 346(13)

MA

(2011) 1903-1908.

[21] Milane L, Trivedi M, Singh A, Talekar M, Mitochondrial biology, targets, and drug delivery,

D

J Control Release. 207(2015) 40-58.

PT E

[22] Ishimoto Y, Inagi R, Mitochondria: a therapeutic target in acute kidney injury, Nephrol Dial Transplant. 31(7) (2016) 1062-1069. [23] Birk AV, Liu S, Soong Y, Mills W, et al., The mitochondrial-targeted compound SS-31

CE

re-energizes ischemic mitochondria by interacting with cardiolipin, J Am Soc Nephrol. 24(8) (2013) 1250-1261.

AC

[24] Tran M, Tam D, Bardia A, Bhasin M, et al., PGC-1alpha promotes recovery after acute kidney injury during systemic inflammation in mice, J Clin Invest. 121(10) (2011) 4003-14. [25] Weinberg JM, Lipotoxicity, Kidney Int. 70(9) (2006) 1560-1566. [26] Liu Y, Ma Z, Zhao C, Wang Y, et al., HIF-1alpha and HIF-2alpha are critically involved in hypoxia-induced lipid accumulation in hepatocytes through reducing PGC-1alpha-mediated fatty acid beta-oxidation, Toxicol let. 226(2) (2014) 117-23. [27] Kamijo Y, Hora K, Tanaka N, Usuda N et al., Identification of functions of peroxisome proliferator-activated receptor alpha in proximal tubules, J Am Soc Nephrol. 13(7) (2002) 1691-702. 24

RI

PT

ACCEPTED MANUSCRIPT

AC

CE

PT E

D

MA

NU

SC

Graphical abstract

25